(1), a nonintercalative antitumor antibiotic, induces mammalian topoisomerase II dependent DNAcleavage1}, it is a potent inhibitor of viral reverse transcriptases2). Severe side effects of 1 resulted in discontinuation of its clinical application as an antitumor drug. Streptonigrone (2) is a minor component in culture broth of Streptomyces 1 143) or Streptomyces albus var. bruneomycini^, producing streptonigrin. 2 has lower cytostatic and antibacterial activities than 1. Until now total synthesis of streptonigrone has not been described. The search for new methods of 1 and 2 modification and biological evaluation of new antibiotic derivatives represent a part of screening program for novel antitumor or antiretroviral semisynthetic antibiotics of streptonigrin series.
Though streptonigrin C-2'-carboxylate is very important for observable biological activity the main direction of 1 modification was derivatization of this group what led to different streptonigrin amides, esters, hydrazides and other derivatives (e.g.2'5~8)).
Other positions of streptonigrin molecule are less available for modification; the only exception being preparation of methyl ester of 8'-<9-methylstreptonigrin (3) by methylation of 1 with (CH3)2SO4 in the presence of K2CO39).Besides this several quinone-imine type derivatives of 1 were described10'11}.
We now report an unusual transformation of streptonigrin (1) into streptonigrone (2) and the synthesis and antibacterial evaluation of 8'-0-alkyl derivatives of 1 and 2. The interest to O-alkyl ethers of streptonigrin is stimulated by the analysis of structure-activity relationships in the series of antitumor anthracycline antibiotics which showedthat the compoundswith unsubstituted phenolic group and their analogs with alkylated OHgroup differ in their cytotoxic and antitumor properties (e.g. carminomycin-daunorubicin)12), the (9-substituted compounds having higher pharmaceutical index than their O-unsubstituted congeners.
The initial step of transformation was carboxylic group protection. This promoted us to investigate the transformation of 1 in similar conditions. Wehave transformed 1 into 2 over Pd-C or Pd-black in a yield of20%in the stream ofH2 at room temperature. The obtained streptonigrone is identical with the natural compound (HPLC, UV, IR and *H NMRdata) 3'4) . Though the mechanismof streptonigrin transformation into streptonigrone still has to be clarified, decarbonylation over Pd could be assumed to be a path of streptonigrone formation. The extremely easy conversion of 1 or diphenylmethyl ester 4 into 2 or its methyl ether 7 are rather unusual and intriguing examples of decarbonylation reaction. Decarbonylation of carboxylic acids has not been described previously; however decarbonylation of acyl chlorides and aldehydes over Pd and its salts is well known13). As 8'-0-methylstreptonigrin is not formed in these conditions it suggests that the limiting stage of the reaction is deblocking of carboxylic group while the transformation of carboxylic group into hydroxy group is very fast.
Earlier it has been supposed that the biosynthetic conversion of 1 or a precursor to 2 would involve decarboxylation and oxidation steps or alternatively covalent hydration of l',2' bond of the pyridine ring followed by oxidative decarboxylation of the resulting a-hydroxylic acid3). These pathways of streptonigrone formation over Pd in H2 stream at room temperature seem to be less probable than the decarbonylation reaction.
Two new derivatives 8 and 9 were obtained by methylation of 2 with Me2SO4in dioxane in the presence of K2CO3. They were separated by chromatography method and isolated in 26% (8) and 20% (9) yields, respectively. XHNMRspectra showed that 8 and 9 are tetramethyl derivatives of 2. Once it is knownthat alkylation of2-pyridone yields N-and 2-O-alkyl derivatives14), we supposed that the compounds 8 and 9 differ in the position of Me group in C ring. Methylation of 1 by Me2SO4in the presence of K2CO3was described to give the dimethyl derivative 3, amino groups being not touched in these conditions9). As in 2 the ABrings are similar to ABrings of 1 it suggests that methylation of2 is directed also towards 8 -OH and 5'-NH2 groups. For the compound 8 the structure oftri-1 \5^5'-A/;A/;^mono-8'-0-methylstreptonigrone was proposed, for the compound9 the structure of di-2',8'-O-di-5',5'-N,AT-methylstreptonigrone.
Both compounds move in paper electrophoresis at pH 2 (E8 0.10, E9 0.13), the E values being close to that of streptonigrone (E2 0.09) and its 8'-0-methyl derivative 7 (E7 0.07); 1 does not move in paper electrophoresis in these conditions. As in 2 the substituents in C ring are different from substituents in C ring of 1 it suggests that the mobilities of 2, 7, 8 and 9 in electrophoresis at pH 2 depend on basicity of aminagroup in C ring. The direction of streptonigrone methylation in 8 and 9 was unambiguously confirmed by 2D 13C-1H chemical shift correlation spectroscopy via long-range couplings using standard pulse sequence HETCOR1 5). The HETCOR spectra of 8 and 9 showed the following relevant correlations: protons of 5'-NMe and carbon C-5', protons 12'-H, 8'-OMe and carbon C-8'. In the HETCOR-spectrumof 8 connectivities of protons 3'-Me and l'-NMe with C-2' was observed, while in the spectrum of 9 C-2' exhibits cross peaks to protons 3'-Me and 2-OMe(see the Table 1) .
Analysis of conformation of streptonigrin and its derivatives using Desktop Molecular Modelling Programme (Oxford Electronic Publishing, 1988) 16) demonstrates the planar chirality of 1, depending on D ring being out of the plane ofAB and C rings, while in the compounds 8 ( Fig. 1) and 9 (Fig. 2) all three ring systems-AB, C and D are noncoplanar and the rotation around N5,-C bond is restricted. Antimicrobial Activity Antibacterial activity of 8'-ethers of streptonigrin (6a, 6b, 6c) in comparison with the parent antibiotic FEB. 1992 Table 1 . 13C assignments of compounds (8) and (9) Data were obtained from long-range C/H-correlation spectra. Signal assignments may be interchanged.
Broad signal.
1, its esters 3 and 10 as well as antibacterial activity of streptonigrone (2) and its derivatives 7, 8, 9 against Bacillus subtilis and Bacillus micoides was investigated on agar mediumby the paper-disk method (lOmg/disk) (see the Table 2 ). Amongall tested new compounds 6a, 6b and 6c demonstrated the most pronounced activity which is lower than that of 1. Streptonigrone derivative with fixed pyridone structure (8) Diphenylmethyl Ester of 8'-Methylstreptonigrin (5a) To a solution of4 (lOmg, 0.015mM) in DMSO(3ml) tert-BuOK (obtained from 0.58mg, 0.015mM of K) and methyl iodide (0.1 ml, 1.25mM) were added. The reaction was stirred for 1 hour, ethyl acetate (30ml) was added and the mixture was washed with water (10ml x 3). Organic phase was concentrated to dryness under reduced pressure, the residue was dissolved in minimal amount of chloroform and then was purified by column chromatography in chloroform-hexane (1 : 2) mixture to give 6.0mg (58.5%) of 5a, Rf0.63 (A). XHNMR(400MHz, C6D6) 3 (ppm), /(Hz):
9. 3.71, 3.46, 3.36 (3H, 3H, 3H, 3H, s, s, s, s, 4OCH3 ), 3.28 (1H, s, CH), 2.51 (3H, s, CH3).
Diphenylmethyl Ester of 8'-O-Ethylstreptonigrin
(5b) 5b (ll.1 mg, 30.2%) was obtained from 35mg (0.052mM) of4, tert-BuOK (from 2.2mg, 0.052mM of K) and excess ofEtI (0.5ml) in a procedure analogous to 5a. Rf0.66 (A). XH NMR(400MHz, C6D6) 3 3.77, 3.71, 3.46 (3H, 3H, 3H, s, s, s, 3OCH3), 3.22 (2H, t, OCH2) , 2.51 (3H, s, CH3), 1.26 (2H, m, CH2) , 0.52 (3H, t, CH3).
8'-0-Methylstreptonigrin (6a) 5a (6.0mg) was dissolved in CH2C12 (lml), the mixture was cooled to 0°C and 0.5ml of CF3COOH-CH2C12 mixture (1 : 1) 10mg of 5a was dissolved in ethyl acetate-methanol mixture (1 : 1), Pd-black (10mg) was added and the reaction mixture was stirred in H2 stream for 6 hours. Then the mixture was filtered, evaporated in vacuo, the dry residue was dissolved in CHC13 and purified on silica gel layer in A system. 7( 2.8mg, 28%) was obtained after eluation with CHC13. Rf0.32 (B), mp 277~278°C, UV A*£Hnm (s) 415 (14,000); MS m/z 492 (M+\ C25H24N4O7). XH NMR (400MHz, CDC13) S (ppm), /(Hz): 8.48 (1H, d, J3A=9A, 3-H Transformation of Streptonigrin (1) into Streptonigrone (2) 30mg of 1 was dissolved in ethyl acetate-methanol mixture (1 : 1), Pd-black (30mg) was added and the reaction mixture was stirred in H2 stream at room temperature for 6 hours. The mixture was filtered, the filtrate was evaporated in vacuo, dissolved in chloroform and purified on silica gel in B system to give 6.5mg (20%) of2. Rf0.58 (B). mp >300°C (dec), UV^?Hnm (s) 340 (13,000) (pH <7), 420 (14,000) (pH 7), 1H NMRspectrum and HPLCdata are identical to the spectrum and HPLCdata of the natural compound obtained by the method4).
r^'^'-A^-Trimethyl-S'-O-methylstreptonigrone (8) and S'^'-TV-Dimethyl^'^'-O-dimethylstreptonigrone (9) Streptonigrone (2) (24mg, 0.05 mmol) was dissolved in dioxane, 0.071 ml (0.7mmol) of Me2SO4 and 77.6mg of dry K2CO3(0.71 mmol) were added. The reaction mixture was stirred during 72 hours at room temperature, then was filtered, evaporated in vacuo, the dry residue was dissolved in CHC13and the obtained compoundswere chromatographed on silica gel in B system to afford the compounds8 (mp 154~155°C, UV /l^Hmn (e) 270 (21,000), 320 (13,000); EI-MS m/z 534 (M+', C28H30N4O7), 519
